US challenges 'bogus' patents on Ozempic, other drugs in effort to spur competition
Tuesday, April 30th 2024, 5:24:15 pm
article
The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic
Breaking
The inquiry could result in disciplinary action ranging from a private reprimand to a requirement that the students withdraw from the university entirely....
Kevin Hassett discusses a $1.3K rise in real incomes under Trump, contrasting with Biden's economic policies....
